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ABSTRACT 
High performance with stability, easy-handling electrodes, and biofluid-flow controllable 
system with mechanical strength of the biofuel cell can be considered as the critical issues for 
future human body implant. These three challenges are sufficiently considered by using the 
effective platform regarding the high surface area from multi-walled carbon nanotube-
conducting polymer with poly(3,4-ethylenedioxythiophene), and size/shape dependent flexible 
yarn electrodes for the implantation of biofuel cell. High power biofuel cell of mW cm-2 range 
in physiological condition (low glucose-containing phosphate buffered saline solution and 
human blood serum) controlling the stirring degree is also first demonstrated for future 
implantation in this study. Biofuel cells for future implantation in human body vitally require 
long-term stability and high power outputs. We have demonstrated that a high-surface area 
yarn-based biofuel cell retained over 70% of its initial power output after an extended 20 days 
period of continuous operation in human blood serum, while delivering a power density of ~1.0 
mW cm-2. Subsequently, our enhanced enzymatic biofuel cell system would be potentially used 
as an innovative power source for the next generation implantable electronics. 
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1. Introduction 
Biofuel cells (BFCs) are of great interest as power sources for implanted miniaturized 
biomedical devices since they offer continuous power supply through conversion of 
biochemical fuels, such as glucose [1]. Implantable electrodes (or devices) need to satisfy many 
criteria such as biocompatibility, miniaturization, easy-handling, robustness, high power 
output, high durability, and long-term stability.  
To date, the best performing BFCs operating in near physiological conditions have generated 
a power density of the order of 1 mW cm-2. Kim and Yoo have reported an output of 0.64 mW 
cm-2 in serum condition that operated stably for eight days [2]. In another recent result, a 
maximum power density of 0.11 mW cm-2 was reported in human serum (10 mM glucose 
solution) [3]. We have recently also reported a BFC operating for 2 days and producing ~1 mW 
cm-2 in both low concentration glucose, 7 mM, in phosphate buffered saline (PBS) and in 
human blood serum (HBS) [4]. Power generation was even lower in implanted BFC operating 
in a live cockroach [5]. Under 50 mM trehalose in PBS solution and cockroach hemolymph 
(ca. 5%) the power outputs were 15 µW cm-2 and 55 µW cm-2, respectively.  
Enzyme-loaded BFC electrodes tend to suffer degradation due to the presence of chemical 
species, such as urate, chloride ion, and ascorbic acid which exist at high level in the biological 
systems like HBS [6]. Urate induces remarkable deactivation of bilirubin oxidase as commonly 
used in the BFC cathode and ascorbic acid decreases the open circuit voltage. As a 
consequence, BFC performance can deteriorate within hours of operation in physiological 
conditions. Our enzymatic BFC system was effectively operated with no significant 
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performance loss and stability decline for two days in HBS. The electrodes consist of porous 
yarns of multi-walled carbon nanotubes (MWNT) coated in poly(3,4-ethylenedioxythiophene) 
(PEDOT) and incorporating electrode specific enzymes and redox mediators. The high stability 
and tolerance to antagonistic chemical species was ascribed to the cation-exchange nature of 
the PEDOT that reduced the rate of degradation without compromising electrode conductivity 
[4]. These fiber type electrodes have high surface area to volume ratios and can be assembled 
into compact, robust systems, such as woven textiles [4].  These characteristics favorably 
compared with film [7] or disk [8] type electrodes that can have relatively low volumetric 
power density and can be difficult to insert and handle.  
BFC power output is dependent on glucose concentration which is also related to blood flow 
rates in implanted devices. We have shown in our recent study [4] that power output can be 
doubled by increasing the glucose concentration from 7 mM to 60 mM in PBS. Normal blood 
flows are very different around major organs such as the heart, liver, or kidney [9]. Yet only a 
few studies have reported on the effect of biofluid flow on BFC power output [10, 11]. In one 
recent example, an implantable biofuel cell system was used with lobsters [12] to mimic human 
blood circulation for a resting person (58.9 μl min-1) and a person performing physical activity 
(235.6 μl min-1). These markedly different flow rates highlight the importance of characterising 
BFC performance under different flow conditions, such as by varying stirring speeds.  
Here we investigate further the BFC performance in physiological conditions of the 
MWNT/PEDOT yarn based enzymatic electrodes. In particular, we consider the effect of 
electrolyte flow rate on BFC power output to determine the likely influence of varying blood 
flow rates. Secondly, we evaluate the performance of the BFC during continuous operation up 
to 20 days.  
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2. Experimental  
2.1. Materials 
MWNT forests (~400 mm high and consisting of ~12 nm diameter nanotubes) were grown 
on a Si wafer by chemical vapor deposition. PVA (Mw 146,000–186,000), iron(III) p-
toluenesulfonate hexahydrate (Fe(III)PTS), pyridine (anhydrous, 99.8% purity), 1-butanol 
(~99% purity) and 3,4-ethylenedioxythiophene (EDOT, 97% purity) were from Sigma-Aldrich 
Corporation and 1M aqueous sulphuric acid solution was from Daejung Chemicals and Metals 
Company. The guests of BFC electrode consist of redox mediator, enzyme, and cross-linker. 
The anodic redox mediator I was PVI-Os(dmo-bpy)2Cl
+/2+, poly(N-vinylimidazole)-[Os(4,4′-
dimethoxy-2,2′-bipyridine)2Cl])
+/2+, and the cathodic redox mediator II was PAA-PVI-Os(dCl-
bpy)2Cl
+/2+, poly(acryl amide)-poly(N-vinylimidazole)-[Os(4,4′-dichloro-2,2′-
bipyridine)2])
+/2+. Glucose oxidase (GOx) from aspergillus niger (219 U mg-1) from Amano 
Enzyme Inc. (Japan) was used as an anodic enzyme. Bilirubin oxidase (BOD) from 
myrothecium verrucaria (10.5 U mg-1, Sigma Aldrich was used as a cathodic catalyst. 
Poly(ethylene glycol) diglycidyl ether (PEGDGE) from Polysciences, Inc was used to cross-
link each enzymes and redox mediators. Human blood serum (HBS) was purchased from 
Biological Specialty, USA. Glucose level of HBS was 4 mM ~ 7 mM, as they reported.  
2.2. Characterizations and electrochemical measurements 
 Surface morphologies of BFC electrode were characterized using scanning electron 
microscopy (Hitachi S4700). For electrochemical measurements, linear sweep voltammetry 
was obtained using electrochemical analyzing system (CHI 627B from CH Instruments). A 
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three-electrode electrochemical system was used for cyclic voltammetry and 
chronoamperometry. A biscrolled yarn electrode was used as the working electrode, with 
Ag/AgCl reference electrode and a Pt mesh counter electrode. The measurements 
wereconducted at 37 ºC under the same condition with the human body in an electrochemical 
cell containing 50 mL PBS solution (20 mM phosphate, 0.14 M NaCl, pH: ~7.4) or HBS.  
2.3. Fabrication of BFC biscrolled yarn electrodes 
 Biscrolled yarn was fabricated with a PEDOT-coated MWNT sheet and guest materials. 
Guests-filled PEDOT-coated MWNT sheet was slowly twisted using the motor with ~5,000 
turns per meter of inserted twist per yarn length. After twist insertion, both ends of the 
biscrolled yarn were fixed to the glass slide using carbon tape and BFC biscrolled yarn was 
cured at 4 ºC for 24 h. Both the anodic yarn electrode (3.5-mm-long, 90-µm-diameter) and the 
cathodic yarn electrode (4.0-mm-long, 80-µm-diameter) were used and an active external 
surface area was 1.01 mm2 for this study.  
 
3. Result s and Discussion 
3.1. Yarn-based anodic and cathodic electrode performance considering the flow of human 
body fluids 
The complete BFC system is introduced in Fig. 1. PEDOT-coated MWNT sheets was used 
as a host material for our enzymatic BFC system. This PEDOT-coated MWNT sheet was 
dipped into each guest solution specifically developed for anodic and cathodic electrodes (Fig. 
1a). Twisting the sheet (Fig. 1b) completed the fabrication of the biscrolled yarn electrodes for 
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both anode and cathode. Scanning electron microscopy (SEM) image shows BFC electrode 
surface in Fig. 1c revealing the PEDOT-coated MWNT bundles. Enlarged surface and cross-
section images are shown in Fig. 1d,e. The cross-section clearly shows the porous vascular 
structure that is important for fast mass transport of the fuels, glucose and oxygen, to the 
reaction centres imbibed within the PEDOT coating.  
The electrochemical characterization of the enzymatic BFC electrodes were measured in two 
buffer conditions, PBS containing low glucose and HBS, and at different stirring rates. Anodic 
current densities were measured at various glucose concentrations from 0 to 15 mM in PBS 
(Fig. 2a). Power densities increased almost linearly with glucose concentration over this range. 
Higher power outputs at a given glucose concentration were achieved with more intense stirring 
of the buffer solution. Linear sweep voltammetry was conducted at a glucose concentration of 
7 mM, which is similar to that of HBS. The linear sweep clearly show the current limited by 
concentration polarization at potentials above ~0.05 V. The maximum anodic current densities 
were higher in PBS than in HBS and increased by moderate stirring at 500 rpm. The maximum 
current density (from the average value of the range between +0.2 V and +0.4 V), as shown in 
Fig. 2b was 4.7 mA cm-2 without any stirring effect and 5.5 mA cm-2 with 500 rpm in PBS 
containing 7 mM glucose fuel, and 4.0 and 5.2 mA cm-2 in HBS. These current densities are 
relatively high compared to the previously reported result of 0.6 mA cm-2 under physiological 
condition (quiescent solution, air, PBS buffer, 15 mM glucose, 37 ºC) [13]. 
Cathodic current density performance is shown in Fig. 3a. Without any stirring, a maximum 
current density of 2.3 mA cm-2 in PBS with 7 mM glucose fuel and 2.2 mA cm-2 in HBS were 
obtained from the average value of the range between -0.1 V and +0.1 V. 
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These values increased under mild stirring (500 rpm) to 3.1 mA cm-2 in PBS with 7 mM 
glucose fuel and 2.8 mA cm-2 in HBS. Current densities of cathode were further increased by 
increasing the stirring degree from 0 to 1,000 rpm, as shown in Fig. 3b. With the stirring of 
1,000 rpm, the cathodic current densities of 3.5 mA cm-2 in PBS with 7 mM glucose fuel, and 
2.9 mA cm-2 in HBS were acquired. The more stirring degree was increased, the more cathodic 
current density was increased and respective error was also inclined to increase [14].  
The electrocatalytic behaviors were investigated by means of cyclic voltammetry 
(Supporting Information, Fig. S1) and electrochemical impedance spectroscopy (Supporting 
Information, Fig. S2). The impedance spectra shapes were similar for both anode and cathode, 
and the electron-transfer resistances correspond to ~175 Ω, for anode and ~286 Ω for cathode, 
respectively. These electron-transfer resistances of the biofuel cell represent the internal 
resistances of the biscrolled yarn electrode containing different enzyme under the 
physiologically relevant operating conditions.  
3.2. Power output based on the body fluid flow  
Power density curves of our BFC in a quiescent solution are shown in Fig. 4a. A maximum 
power density of 1.2 mW cm-2 was obtained at an operating voltage of 0.46 V when using 7 
mM glucose PBS buffer, and 1.1 mW cm-2 was obtained at 0.50 V in HBS. Open circuit voltage 
was 0.83 V and 0.80 V, respectively, in these two physiological conditions. The open circuit 
voltage in generally lower than that under glucose-containing PBS buffer condition, according 
to the reports [15]. It was previously demonstrated with two reasons, oxygen concentration for 
cathode fuel is very low, compared to PBS solution, and the dissolved oxygen may partially 
react with glucose at the anode. (Isolating the anode and cathode fluid, and removing the 
oxygen from anode fluid will improve the open circuit voltage, but it is difficult to achieve it 
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in implanted devices, using both oxygen and glucose from the same biofluid.) The obtained 1.1 
mW cm-2 maximum power density is higher than a reported maximum power density (0.64 
mW cm-2) [2] in serum containing 10 mM glucose solution, at the scan rate of 40 mV s-1. In 
addition, the volumetric power densities were 278 mW cm-3 and 252 mW cm-3, in 7 mM 
glucose-containing PBS solution and HBS, respectively. Additionally, our gravimetric power 
outputs were 95 mW g-1 in 7 mM, without stirring. 
In Fig. 4b, power densities obtained by changing the stirring ratio and representing the effect 
of varying blood flow rates are represented. As increasing the stirring degree from 0 to 1,000 
rpm, power density was also increased, up to 1.6 mW cm-2 in low glucose-containing PBS 
buffer and 1.2 mW cm-2 in HBS, respectively. These stirring degree-dependent power output 
are relevant since the flow rate of fluids in animals or humans varies throughout the body (for 
example, 0.5 L min-1 near liver, 0.55 L min-1 near kidney, and 5.25 L min-1 near heart of human 
body [9]).  
This exceptional performance realized for the biscrolled yarn BFC results in part from the 
yarn’s three-dimensional vascular structure. The corridors between scrolled PEDOT/MWNT 
sheets in the biscrolled yarn provide a continuous internal pathway for rapid glucose and 
oxygen diffusion and ion transport from yarn surface to yarn center, as well as sufficient 
porosity through scroll layers for cross-layer transport. Our enzymatic BFCs describing high 
power output performance in physiological conditions (glucose-containing PBS buffer and 
human body fluid) contribute to provide feasible power source for energy generation 
considering future human body implants.  
3.3. Enzymatic BFC stability in HBS 
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BFC stability is considered as a critical issue related to the effective enzyme immobilization 
for both anode and cathode. In most previous studies, the enzymatic electrodes in HBS showed 
rapid deterioration within a few hours of operation [16, 17]. Reversible deactivation and 
irreversible damage of bio-cathode could also decrease the stability of the BFC device. 
Attempts to improve the stability of enzymatic BFCs have resulted in recently reported BFC 
(0.64 mW cm-2) [2] in serum condition provided the stability for eight days, while another work 
(0.11 mW cm-2) [3] showed only 43% stability based on the remaining percentage from the 
initial power density value after 3 days. 
Previous investigations of enzymatic PEDOT/MWNT yarn type BFCs were restricted to 2 
days of continuous operation. Here the time dependence of the power density of the cell poised 
at 0.40 V in 7 mM glucose-containing PBS solution and HBS under air at 37 °C is shown in 
Fig. 5a. Based on the initial power density, the BFC retained 81% of power density in PBS 
under 7 mM glucose buffer solution, and 72% in HBS after 10 days with continuous operating. 
After 20 days, the power outputs of biofuel cell remained at 80% and 71% in 7 mM glucose-
containing PBS and HBS, respectively. After 28 days of continuous operation the retained 
power densities were ~77% for glucose-containing PBS buffer, and ~68% for HBS.  
The enhanced BFC stability of the system described here was based on the three following 
reasons. First, the performance can be effectively maintained by inducing electron transfer 
between electrocatalytic enzymes and redox mediators immobilized on fuel cell electrodes. All 
trapped enzymes and redox mediators are activated in the yarn electrode with structural 
advantage, accentuated by the layer by layer structure [18] which is made by biscrolling method 
[19], as shown in Fig. 5b (left). This biscrolling structure effectively traps enzymes in the 
electrode, and plays an important role to enhance the stability of the enzymatic BFC system. 
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Second, the MWNT-based BFC yarn electrode itself was porous and highly electronically 
conductive providing efficient current collection, and good permeability based on the host 
material containing PEDOT to act as a bridge between enzymes and electrode surface. Third, 
conducting polymer, PEDOT, coated on the MWNT sheets by vapor phase polymerization 
could protect inner layers of the electrode from the outer layers of the electrode surface. These 
phenomena were described in details with the repulsive force [20] between immobile SO3
- 
anionic ions from tosylate-doped PEDOT and chloride ions in body fluids, as shown in Fig. 5b 
(right). The hydrophilic PEDOT conducting polymer coating on the nanotubes not only 
enhances nanotube wettability, connectivity, and conductivity [21], but also enhances electrode 
stability in human body fluid [22]. Therefore electrolyte accessibility is provided within the 
entire yarn volume, while incorporation of anionic chemical species such as urate, chloride, 
and ascorbic acid is avoided. Suitable stability in HBS can be attributed to electrostatic 
interaction that renders the dopant anions relatively immobile in the conducting polymer. 
Hence, the PEDOT coating on the MWNTs acts as a cation exchange membrane [22]. As a 
result, we showed that long-term test of BFC was feasible in low glucose level-containing PBS 
solution and HBS, and raised the possibilities applying to biomedical devices as potentially 
implantable BFCs.  
 
4. Conclusions 
Here, improved BFC power output and long-term stability performances were demonstrated 
in low glucose level PBS solution and human body fluid. We showed remarkable power output 
performance and stability of the full BFC system, exceeding all previous systems to the best of 
our knowledge, in physiological conditions. We suggested compact, flexible, and easy-
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handling implantable BFC electrodes. In addition, the influence of biofluid flow rate has been 
explicitly investigated as is important for real animal/human implantations. These 
performances are particularly encouraging for harvesting energy by inserting devices inside the 
human body with internal biomedical devices. 
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Fig. 1. Yarn-based enzymatic BFC electrode. a) Deposition of guest materials, such as enzyme, 
redox mediator, and cross-linker on the PEDOT/MWNT sheet. Scale bar is 3 mm. b) Optical 
image of twisting process for fabricating the biscrolled yarn electrode. Scale bar is 1.5 mm. 
The fabricated biscrolled yarn electrode (indicated by yellow color, dashed square) was 
enlarged in Fig. 1c. c) SEM micrograph showing the surface of BFC yarn cathode electrode 
(Scale bar: 20 μm). d) Enlarged SEM image of surface morphology. Scale bar, 2 μm. e) SEM 
cross-section image of three dimensional BFC yarn electrode structure (Scale bar: 5 μm). The 
inset illustrates a dual Archimedean scroll. 
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Fig. 2. Anodic performance depending on the stirring degree in physiological conditions. a) 
Anodic current density changes according to the concentration of the glucose fuel from 0 to 15 
mM with three stirring conditions, 0 rpm, 500 rpm, and 1,000 rpm. The error bars show the s.d. 
from the current densities for three independent experiments. b) Polarization curves of the 
anodic current densities under PBS containing 7 mM glucose (red) and HBS (blue) with no 
stirring and 500 rpm.  
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Fig. 3. Cathodic performance depending on the stirring degree in physiological conditions. a) 
Polarization curves of the cathodic current densities under PBS containing 7 mM glucose (red) 
and HBS (blue) with no stirring and 500 rpm. b) Maximum current density changes by stirring 
(0, 500, and 1,000 rpm) in 7 mM glucose-containing PBS buffer and HBS. The error bars show 
the s.d. from the current densities for three experiments. 
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Fig. 4. Enzymatic BFC power densities in physiological conditions. The error bars show the 
s.d. from the power densities for three cases. a) Power densities of BFC without stirring under 
physiological conditions (7 mM glucose-containing PBS and HBS). Inset: Complete BFC 
system consisting of anode (indicated with red color) and cathode yarn (indicated with blue 
color) parallel wrapped around a glass rod to avoid short circuiting, immersed in HBS and 
continuously operated at 37 ºC with stirring. b) Power density changes by increasing the stirring 
degree from 0 to 1,000 rpm, at an interval of 250 rpm, in glucose-containing PBS buffer and 
HBS. 
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Fig. 5. Enzymatic BFC stability in PBS with 7 mM glucose and HBS. a) Normalized power 
density (P/P0, P is the power output of the cells, and P0 is the initial power output at the starting 
point of operation) data of BFC system in PBS containing low glucose level (red) and HBS 
(blue) with stirring, 500 rpm for 20 days. The error bars show the s. d. of normalized power 
density for three cases. Inset: Experimentally measured power outputs in two operating 
conditions. b) Schematic illustration of the enzyme-protecting effect of PEDOT layer acting as 
a cation exchange membrane in the BFC electrode. 
